Skip to content
Precision for Medicine
iStock-1500823492 (1) iStock-1500823492 (1)

Streamline Your Study Start Up with Precision

Kickstart your clinical trials with efficiency and expertise.
In today’s fast-paced clinical trial environment, initiating your study effectively is more critical than ever. Precision's approach to Study Start Up combines technological innovation, regulatory insight, and global expertise to optimize every phase of trial initiation, ensuring your study begins with the momentum needed to succeed.
iStock-1332002332 (1) (1)

Accelerating your clinical trial start up

Successful clinical trials begin with a well-executed study start up. By focusing on strategic site selection and swift regulatory submissions,  Precision’s global study start up team helps set the foundation for timely and successful trial outcomes. Our team delivers site activation with precision by leveraging locally dedicated staff and through close partnership with our Regulatory Affairs department. Through this synergy, we streamline submissions across North America, Europe, and Asia Pacific. Every study presents its own unique challenges therefore it's critical to work with seasoned staff dedicated to guiding effective study start up.
5 Average years of start up experience
45 countries supported by Precision’s Start Up team

Our Proven Pathway to Study Start Up Success

Precision's study start up services are built on a foundation of detailed planning and proactive strategy. From identifying the most suitable sites worldwide to navigating the complexities of local and global regulations, our team ensures your study is initiated without delay. With a focus on cross-functional collaboration, accountability, and proactive risk management, we partner with you to accelerate patients' access to life-changing therapies.
The Precision path

Expert perspectives from Precision

Gain new insights and strategies from our experts at the forefront of clinical and translational research.

Read: Mining for Gold? Prospecting Biospecimen Collections to Power Precision Medicine Mining for Gold? Prospecting Biospecimen Collections to Power Precision Medicine

Translational Research - Biospecimens

Mining for Gold? Prospecting Biospecimen Collections to Power Precision Medicine

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=193399854592, hs_child_table_id=0, hs_updated_at=1753811966605, hs_published_at=1753981935867, description=George Rogers is a scientific storyteller with over two decades of experience translating complex biology into content that connects. At Precision for Medicine, he facilitates scientific content development, crafting articles, case studies and presentations that spotlight the company’s integrated support for sponsors, from biomarker discovery and translational science to clinical trial execution and regulatory guidance. George’s background in cell analysis and drug development informs his ability to turn complex science into clear, compelling narratives that support business development and drive engagement across the life sciences landscape., avatar=Image{width=800,height=798,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Geaorge%20W%20Rogers%2c%20PhD.jpg',altText='Geaorge W Rogers, PhD',fileId=193407923546}, lastname=Rogers, PhD, hs_initial_published_at=1753469768389, hs_created_by_user_id=26433386, hs_created_at=1753469702664, hs_is_edited=false, hs_deleted_at=0, name=George, job=Senior Manager, Scientific Content, slug=george-rogers-phd, hs_updated_by_user_id=51739740}, second={}, third={}})
  • George Rogers, PhD avatar

    George Rogers, PhD

Discover
Read: Case Study: Early Genotype Confirmation Rescued a Phase 1-2 SCID Trial Case Study: Early Genotype Confirmation Rescued a Phase 1-2 SCID Trial

Clinical Trials - Rare Diseases

Case Study: Early Genotype Confirmation Rescued a Phase 1-2 SCID Trial

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=164725548848, hs_child_table_id=0, hs_updated_at=1716454310949, hs_published_at=1753981935867, description=Alexis Hobbins-White is an accomplished leader who plays a pivotal role in navigating the complex landscape of global oncology and rare disease-focused clinical trials. With a career spanning over 15 years in the clinical trials industry, Alexis brings a wealth of experience across multiple therapeutic areas, showcasing her proficiency in diverse aspects of operational strategy. She specializes in early phase adaptive studies, particularly in immuno-oncology and advanced therapeutics. She has an MSc in Neuroscience and an MA in Biotechnology Law and Ethics., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/Alexis-Hobbins-White-150x150.jpeg',altText='Alexis-Hobbins-White-150x150',fileId=164710912635}, linkedin=https://www.linkedin.com/in/alexis-hobbins-white-400a1720/, lastname=Hobbins-White, hs_initial_published_at=1713362276020, hs_created_by_user_id=5166971, hs_created_at=1713361952861, hs_is_edited=false, hs_deleted_at=0, name=Alexis, job=Senior Director, Operational Strategy , slug=alexis-hobbins-white, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Alexis Hobbins-White avatar

    Alexis Hobbins-White

Discover
Read: Phase 3 Prostate Cancer Case Study: Radiopharm Imaging at Scale Phase 3 Prostate Cancer Case Study: Radiopharm Imaging at Scale

Clinical Trials

Phase 3 Prostate Cancer Case Study: Radiopharm Imaging at Scale

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778843, hs_child_table_id=0, hs_updated_at=1714461297945, hs_published_at=1753981935867, description=Robert Bauer is an Executive Director of Operational Strategy at Precision with over 20 years of clinical trial operations experience from both the sponsor and CRO perspectives. He has led teams in the conduct of trials from Phase I through IV and has experience across a wide variety of trial designs. Bob has experience across many therapeutic areas some of which include rare diseases, oncology, depression, schizophrenia, and substance use disorders., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Robert%20Bauer%20Square.webp',altText='Robert Bauer Square',fileId=165892429961}, linkedin=https://www.linkedin.com/in/robert-bauer-a78b704b, hs_name=, hs_path=, lastname=Bauer, hs_initial_published_at=1753811989733, hs_created_at=1709645745074, hs_is_edited=false, hs_deleted_at=0, name=Robert, job=, slug=robert-bauer, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Robert Bauer avatar

    Robert Bauer

Discover
  • Discover Early Phase Excellence
    82 (1)

    Early Phase Excellence

    Embark on the critical first steps of clinical discovery with our expertly managed early phase trials, where meticulous attention meets innovative strategy

    Explore
  • Discover Late Phase Success
    late-phase

    Late Phase Success

    Discover the path to market with our Late Phase Development expertise – delivering precision, scale, and efficiency for your clinical journey.

    Explore

Deep experience with debilitating disease and unique modalities

Like you, we understand that there’s a patient throughout the development pathway. Supporting our partners to bring innovative treatments to patients is our purpose. Leverage our experience in these therapeutic areas.

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global central lab services

    Explore